Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling
Authors
Keywords
Stroma, Proliferation, Angiogenesis, Breast cancer
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-01
DOI
10.1186/1471-2407-14-735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDGF receptor signaling networks in normal and cancer cells
- (2014) Jean-Baptiste Demoulin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting the PDGF signaling pathway in tumor treatment
- (2013) Carl-Henrik Heldin Cell Communication and Signaling
- Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells
- (2013) Christina J. Malavaki et al. FEBS Journal
- Breast cancer: Current and future endocrine therapies
- (2013) Carlo Palmieri et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer
- (2012) M. T. Weigel et al. ANNALS OF ONCOLOGY
- Stromal cells in tumor microenvironment and breast cancer
- (2012) Yan Mao et al. CANCER AND METASTASIS REVIEWS
- Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility
- (2012) M. Annunziata et al. HUMAN REPRODUCTION
- Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
- (2011) Ubaldo E. Martinez-Outschoorn et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer
- (2011) J. Taeger et al. MOLECULAR CANCER THERAPEUTICS
- Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
- (2011) Jan Rykala et al. PATHOLOGY & ONCOLOGY RESEARCH
- An Immunohistochemical Method to Study Breast Cancer Cell Subpopulations and Their Growth Regulation by Hormones in Three-Dimensional Cultures
- (2011) Mauricio P. Pinto et al. Frontiers in Endocrinology
- In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
- (2010) Marion T Weigel et al. BMC CANCER
- Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor–Positive Breast Cancer
- (2010) Mauricio P. Pinto et al. CANCER RESEARCH
- Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells
- (2010) Kinoshita INTERNATIONAL JOURNAL OF ONCOLOGY
- Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers
- (2010) J. T. Camp et al. MOLECULAR CANCER RESEARCH
- Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis
- (2009) N. Song et al. CANCER RESEARCH
- Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer
- (2009) Denise A. Yardley et al. Clinical Breast Cancer
- Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells
- (2009) Yen-Chun Chen et al. LIFE SCIENCES
- Stroma in breast development and disease
- (2009) Lisa M. Arendt et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Serum Insulin-Like Growth Factor-I and Platelet-Derived Growth Factor as Biomarkers of Breast Cancer Prognosis
- (2008) P. Pasanisi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Phase II Study of Imatinib Mesylate and Capecitabine in Metastatic Breast Cancer: Southwest Oncology Group Study 0338
- (2008) Helen K. Chew et al. Clinical Breast Cancer
- Endothelial???stromal interactions in angiogenesis
- (2008) Christopher CW Hughes CURRENT OPINION IN HEMATOLOGY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals
- (2008) Toru Hiraga et al. INTERNATIONAL JOURNAL OF CANCER
- R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
- (2008) Yihai Cao et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
- Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects
- (2007) Ana Rocha et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started